Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
-0.0100 (-3.23%)
Feb 11, 2026, 12:53 PM CET

STO:MODTX Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
7.336.737.836.997.092.3
Research & Development
10.349.078.4810.913.543.72
Other Operating Expenses
-0.010.040.090.120.05-0
Operating Expenses
17.6615.8416.418.0120.696.02
Operating Income
-17.66-15.84-16.4-18.01-20.69-6.02
Interest Expense
-0.41--1.5-0.31-0-0
Interest & Investment Income
0.130.290--0
Other Non Operating Income (Expenses)
-0--0---
Pretax Income
-17.94-15.55-17.9-18.32-20.69-6.02
Net Income
-17.94-15.55-17.9-18.32-20.69-6.02
Net Income to Common
-17.94-15.55-17.9-18.32-20.69-6.02
Shares Outstanding (Basic)
41361816126
Shares Outstanding (Diluted)
41361816126
Shares Change (YoY)
49.01%102.53%10.22%30.09%109.34%-
EPS (Basic)
-0.44-0.43-1.01-1.14-1.67-1.02
EPS (Diluted)
-0.44-0.43-1.01-1.14-1.67-1.02
EBIT
-17.66-15.84-16.4-18.01-20.69-6.02
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.